DC
PJP icon

Davenport & Co’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Davenport & Co’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$354K Buy
+2,867
New +$356K ﹤0.01% 1135

Other funds holding PJP

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return
MWM
MinichMacGregor Wealth Management Saratoga Springs, New York $620M AUM 32.35% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
LWM
Lodestone Wealth Management Spokane, Washington $297M AUM 25.27% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.47B AUM 24.2% 1-Year Est. Return

Davenport & Co's PJP Position: Q3 2026 in Review

Davenport & Co opened a new position in Invesco Pharmaceuticals ETF (PJP) in Q3 2026: 2,867 shares worth $354K. The stake represents ﹤0.01% of the portfolio and ranks #1135 among its holdings.

13 funds tracked by Wall St. Rank hold PJP as of Q3 2026.

  • Davenport & Co held 2,867 shares of Invesco Pharmaceuticals ETF worth $354K as of Q3 2026.
  • Invesco Pharmaceuticals ETF was a new Davenport & Co position in Q3 2026.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of Davenport & Co's portfolio in Q3 2026, its #1135 holding.
  • 13 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2026.

Based on Davenport & Co's 13F filing for Q3 2026, filed 14 Oct 2026.